Senior insider sale
EVP, Business Development at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$1.48M
41.66K shares
What this filing means
LIPPMAN EVAN plans to sell 41.66K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $1.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/14/2026ACC: 0001973379-26-000178
Officer· EVP, Business Development
Since Mar 2026
41.66K
Shares to sell
$1.48M
Approx. market value
85.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
5/14/2025
85.85KTotal acquired85.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2025 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 85.85K | — |
| Total | 85.85K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
41.66K
Market value
$1.48M
5/14/2026
Total
Units
41.66K
Value
$1.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/14/2026 | 41.66K | $1.48M | NYSE | Planned |
| Total | 41.66K | $1.48M | ||